AVR

0.00%

$18.00 anteris technologies ltd

Nice to see a new investor recognise the opportunity and...

First 15 Last

Share
Profile

Follow
Eire2011

2,982 Posts.

1817

13/04/21

10:04

Post #: 52421842
Share

Originally posted by JaneD2010: ↑

Got in yesterday at $10. I was actually surprised it got sold into... didn’t expect $10 to get smashed.

Could still go down further but who knows, sentiment can change

Anyway, the reasons I bought are:

1. It has a low MC (~70 million) for a company that has an FDA-approved product in ADAPT

2. Wayne Paterson as CEO & MD - has extensive experience in biotech (more than 20 years), even sat on the board of a NASDAQ-listed company.

3. If their transcather product works, they will have the most novel aortic stenosis treatment in the world. What do I mean by this? They will have a:

a. material (ADAPT) that doesn’t calcify

b. 3-D anatomically correct valve that promotes better haemodynamics due to its wider opening and therefore less pressure and wear and tear on the valve itself (also prevents calcification). Also needs way way less stitches compared to the current valves that are implanted - this is due to it being single piece.

c. a cathether that hopefully is also novel (i have to read more about this). TAVR is currently being performed worldwide and it does allow patients to recover quickly post-op. If you ask healthcare professionals working or have worked in cardiothoracics, they will tell you that open heart surgeries has plenty of risks compared to TAVRs. Imagine cracking someone’s chest open vs a 40 minute procedure where all the surgeon has to do is insert a catheter in the femoral vein, thread the catheter to the heart and replace the calcified valve with a one-piece valve using a few stitches and the patient could be discharged the next day. In open-heart surgeries, patients sort of “suffer” post op and have to rehab for weeks. Yes I have seen them struggle and in pain.

4. Cashed up at the moment and has a back-up funding from the Mercer deal.

Tick tick tick tick for me.

Goodluck.

Expand

Nice to see a new investor recognise the opportunity and document why they bought. Well doneJane, a great post and welcome.

(and yes the catheter is novel.)

While we have made advances on the delivery system since it was recorded I strongly recommend watching the full version of the companies KOL symposium which can be found here:

https://anteristech.com/news/TAVR-KOL-Symposium

AVR Price at posting: $10.01 Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Bitcoin investors need to know the risks

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

There are more pages in this discussion • 24 more messages in this thread...

First 15 Last

Add AVR (ASX) to my watchlist

(20min delay)
Last $18.00		Change 0.000(0.00%)		Mkt cap ! $346.0M

Open	High	Low	Value	Volume
$18.00	$18.10	$17.70	$58.64K	3.27K

Buyers (Bids)

No.	Vol.	Price($)
1	109	$18.00

Sellers (Offers)

Price($)	Vol.	No.
$18.10	700	1

View Market Depth

No.	Vol.	Price($)
1	109	18.000
1	25	17.800
1	48	17.750
1	220	17.700
1	26	17.650

Price($)	Vol.	No.
18.100	700	1
18.300	150	1
18.500	43	1
18.690	550	1
18.750	143	1

Last trade - 16.10pm 12/07/2024 (20 minute delay)

AVR (ASX) Chart

Nice to see a new investor recognise the opportunity and...

Almonty locks in govt agreement for tungsten oxide plant in South Korea

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Nimy to raise $1.21M to explore 'newsy' WA targets

Immutep reports strong response rate from immunotherapies treating carcinomas

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Bitcoin investors need to know the risks

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Nice to see a new investor recognise the opportunity and...

Top Stories

Almonty locks in govt agreement for tungsten oxide plant in South Korea

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Nimy to raise $1.21M to explore 'newsy' WA targets

Immutep reports strong response rate from immunotherapies treating carcinomas

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Bitcoin investors need to know the risks

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News